|
|
|
|
4 Cellular and Molecular Nutrition and 5 Quality and Purity of Edible Oils, Instituto de la Grasa (CSIC), 41012 Seville, Spain; 6 Centro Andaluz de Biología del Desarrollo, Universidad Pablo de Olavide, 41013 Seville, Spain; and 7 Service of Internal Medicine, Hospitales Universitarios Virgen del Rocío, 41013 Seville, Spain
* To whom correspondence should be addressed. E-mail: muriana{at}ig.csic.es.
| ABSTRACT |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Undegraded postprandial TRL and their remnants remain in blood until they are taken up by hepatic receptors; they can also interact with circulating cells, cross the endothelial layer, and become trapped within the subendothelial space (11). Additionally, recruitment of monocytes into atherogenic foci and their retention within the atherogenic lesion contribute to the progression of plaque development (12). In plaques, monocyte-derived cells (macrophages) recognize postprandial TRL and modified forms of LDL and produce secretory factors that attract and activate smooth muscle cells, other immune cells, and more monocytes (13). In advanced plaques, necrotic lipid-filled cores are formed after lipoprotein-induced cytotoxicity (14). Understanding how monocytes differentiate into macrophages to form foam cells in vitro and in vivo has been the focus of many studies (15,16). However, unprocessed monocytes represent a large pool of circulating precursors that coexist in the blood stream with lipoproteins, mainly postprandial TRL, that carry the majority of circulating TG after a high-fat meal and more CHOL molecules per particle than does LDL (17). Because clinical studies have shown an association between hyperlipidemia and elevated numbers of circulating monocyte-derived phosphatidylserine-positive microvesicles (18), we questioned whether postprandial metabolism of dietary fats might represent a critical element in the survival of monocytes, before they are differentiated. Indeed, phosphatidylserine externalized by apoptotic cells is thrombogenic (19) and if removal of apoptotic cells becomes compromised, secondary necrosis may ensue and propagate inflammation (20). This could be especially important, because monocytes act not only as versatile phagocytic cells under macrophage phenotype but also as a source of migratory dendritic cells able to activate antigen-specific T lymphocytes (21).
Consistent with a previous study suggesting a role for the ratios of oleic:palmitic acid and MUFA:SFA of natural fats in human postprandial events (22), we have herein extended our investigation to further explore the influence of such dietary determinant on the ratio of TG:CHOL in TRL of healthy men at early (3 h) and late (5 h) postprandial periods. In addition, whether postprandial TRL at 3 and 5 h promote changes in cell viability and cycling in THP-1 human monocytic cell line was also assessed.
| Subjects and Methods |
|---|
|
|
|---|
Human postprandial lipoprotein isolation. The isolation of TRL with a Svedberg flotation unit >400 from freshly postprandial plasma samples collected 3 and 5 h after consumption of the test meals was performed as described previously (24). These time points were chosen to compare the most recently (nascent) secreted particles by the intestine with remnant postprandial particles. Total TG and CHOL in postprandial TRL were measured using enzyme-based colorimetric kits supplied by Thermo Trace (Triglycerides GPO and Infinity Cholesterol). For fatty acid composition of postprandial TRL, we used a simple and rapid 1-step lipid extraction and fatty acid methyl esters procedure according to the method of Garces and Mancha (25) with some modifications (Supplemental Table 2). Postprandial TRL were then stored at –70°C until cell studies were conducted.
Cell culture. Nonadherent cells of the human monocytic THP-1 cell line (TIB-202; American Type Culture Collection) were cultured in RPMI 1640 medium supplemented with L-glutamine, penicillin, streptomycin, and 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere of 5% CO2 in air. For treatment, 300,000 cells/mL were incubated in medium containing 0.5% FBS for 24 h. The cells were then stimulated with postprandial TRL at a final concentration of 100 µg TG/mL for an additional 24 or 48 h.
Flow cytometric analysis. Early events associated with apoptosis and necrosis were evaluated using the binding of Annexin V to detect the translocation of phosphatidylserine from the inner side to the outer leaflet of the plasma membrane on apoptotic cells and propidium iodide to DNA on necrotic cells, as described in Vybrant Apoptosis Assay kit number 3 (Molecular Probes). Analysis of stained cells was performed measuring the fluorescence emission on EPICS XL flow cytometer (Beckman Coulter) at 530 nm and 585 nm for fluorescein isothiocyanate and propidium iodide, respectively, using EXPO32 Software (Beckman Coulter). At least 10,000 cells were analyzed and gated according to light scatter properties.
Monocytes were treated as described (26) and analyzed for cell cycle distribution with an EPICS XL flow cytometer (Beckman Coulter) and EXPO32 software (Beckman Coulter). Red fluorescence (585 nm) was evaluated on a linear scale and pulse width analysis was used to exclude cell doublets and aggregates from the analysis. Cells with DNA content between 2N and 4N were designated as being in the G1/G0-, S-, or G2/M-phase of the cell cycle. The number of cells in each compartment of the cell cycle was expressed as a percentage of the total number of cells present.
Statistical analysis. Individual data from each subject were plotted and evaluated qualitatively. Statistical analyses were carried out to compare the effects of each fat on the fasting and postprandial values and to analyze the values from each fat at different time intervals. The net incremental area under the curve (netAUC), including the entire incremental area below the curve and the area below the fasting concentration, was analyzed by a 1-factor repeated-measures ANOVA. A Bonferroni correction or Dunnett's comparison was used for the post hoc detection of significant pairwise differences. After checking for interaction, outcome variables were tested with 2-way ANOVA. The netAUC was calculated by the trapezoidal method using Microsoft EXCEL 2000 v.9 (Microsoft). Univariate correlation analysis between variables was performed with Pearson's product-moment correlations. Each experiment with cells was performed simultaneously on paired samples derived from incubation with 3- and 5-h postprandial TRL from each fat-meal. Within an experiment, triplicate wells were used for each condition or treatment. Results were expressed as means ± SD. Comparisons for the differences between means were performed using the Student's t test. The data were analyzed using STATVIEW v.5 for WINDOWS (SAS Institute). The designated level of significance was P < 0.05.
| Results |
|---|
|
|
|---|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
In addition, delayed postprandial clearance of TG has been reported to increase the exchange of lipids between postprandial TRL and CHOL-rich lipoproteins mediated by CHOL ester transfer protein (CETP) (4). Such reciprocal exchange leads to the formation of postprandial TRL enriched in CHOL, whereas CHOL-rich lipoproteins are enriched in TG (30). The present study shows that the slopes for TG:CHOL and TG clearance in postprandial TRL were the steepest after the ROO meal. We also found evidence of CHOL enrichment of postprandial TRL by measuring the netAUC for CHOL after the VEFO, ROO, HPSO, and butter meals. The ROO meal induced the largest netAUC for CHOL in postprandial TRL, suggesting a high lipid exchange turnover with CHOL-rich lipoproteins. However, oleic acid is a poor activator of CETP when compared with palmitic acid (31). As proposed in previous trials, the transferability of CHOL from donors might relate to its affinity for CETP, which varies according to the fatty acid composition of the diet (5), but also to the (surface) size of acceptors (32). Accordingly, the ingestion of ROO-containing meals has been shown to cause the formation of large postprandial TRL (7), which may thereby facilitate their lipid transfer with CHOL-rich lipoproteins (33). A lower netAUC for CHOL in postprandial TRL after the VEFO meal was consistent with the known CETP-lowering effect of (n-3) LCPUFA (34). We also observed that the butter meal induced the largest netAUC for TG in postprandial TRL and a positive change of CHOL in postprandial TRL from 3 to 5 h, suggesting that a delay in postprandial TRL clearance contributed to their CHOL enrichment in the late postprandial period. This is in agreement with the postprandial response pattern of CETP activity to palmitic acid-enriched meals (5).
We noticed that postprandial TRL were cytotoxic for the THP-1 human monocytic cell line. Postprandial TRL at 3 h preferentially increased necrotic cells, whereas postprandial TRL at 5 h resulted in a shift to increase the apoptotic cells. Unlike apoptosis, necrosis is characterized by cell swelling and bursting before release of cell content, which may induce an inflammatory response. The necrotic effect of postprandial TRL at 3 h was in the following order: butter = VEFO > HPSO > ROO, whereas the order of necrotic and apoptotic effects with postprandial TRL at 5 h was: butter = HPSO > VEFO = ROO. Therefore, postprandial TRL from ROO were less cytotoxic for monocytes and probably more beneficial by preventing acute inflammatory response from necrotic monocytes than VEFO, HPSO, and butter. A number of studies have shown that SFA were quickly incorporated into phospholipids and generate specific pro-cytotoxic lipid species or signaling molecules that were not produced in response to MUFA (35–37). Likewise, oleic acid was found to play an important role in rescuing cells from palmitic acid-induced cytotoxicity in a variety of systems (38). Cytotoxicity of postprandial TRL after the VEFO meal confirmed previous in vitro and in vivo studies showing the capability of EPA and DHA to inhibit cell survival by affecting multiple pathways (39). Our study supports the notion that TG in postprandial TRL may evoke procoagulant (18,19) and proinflammatory (20,40) changes by inducing apoptosis and necrosis of circulating monocytes. However, CHOL or other lipid components of TRL might also be responsible for cytotoxicity toward monocytes (41–43). We do not exclude the possibility that other minor fatty acids could also be involved. Further studies are required to determine whether cytotoxicity of postprandial TRL on THP-1 cells are due to fatty acids intracellularly or extracellularly produced by the action of endogenous lipases (44), which could explain the progressive effects from 24 to 48 h of incubation.
Cell cycle analysis showed that postprandial TRL blocked the THP-1 human monocytic cell line in S-phase and diminished the proportion in G2/M-phase, reflecting inhibition of S/G2 transit or S-phase cell cycle arrest. In addition, the proportion of cells in S-phase increased with the incubation time (mainly with TRL at 5 h postprandial). The decondensation of chromatin in this phase is favored by a decrease of sphingomyelin and an increase of the CHOL free fraction (not linked to sphingomyelin) in the chromatin CHOL, which stimulates the activities of cyclin-dependent kinases (cdk) and contributes to kinase activation and G1- to S-phase progression (45). Members of the cdk-inhibitor family (including p21waf1, p27kip1, and p57kip2) promote cell-cycle arrest by binding and inhibiting cyclin E-cdk2 and the D cyclin-cdk4/6 protein complexes in response to toxic stress (46). Importantly, fatty acids and other PPAR
ligands may modify the expression and/or protein degradation at least of p21waf1 and p27kip1 (47–49), supporting a model wherein fatty acids from TG of postprandial TRL lead to regulation of the cell cycle.
In conclusion, data presented here show a link between the ratios of oleic:palmitic acid and MUFA:SFA in dietary fats and the level of TG and CHOL in postprandial TRL of healthy men. Our observations further support the importance of the magnitude and duration of the postprandial response to high-fat meals in postprandial TRL remodeling. In agreement with a general belief that MUFA are less atherogenic than SFA, postprandial TRL from ROO elicited less adverse cytotoxic and cell cycle effects on THP-1 cells than dietary fats rich in SFA (butter and HPSO) or containing a low amount of (n-3) LCPUFA (VEFO). This study could be of particular relevance for the clinical outcomes of subjects with visceral obesity, insulin resistance, type 2 diabetes, type III hyperlipidemia, familial combined hyperlipidemia, and other constitutional, environmental, hormonal, and genetic factors who have pathologically exacerbated and delayed postprandial response to the ingestion of dietary fats.
| FOOTNOTES |
|---|
2 Author disclosures: S. López, B. Bermúdez, Y. M. Pacheco, G. López-Lluch, W. Moreda, J. Villar, R. Abia, and F. J. G. Muriana, no conflicts of interest. ![]()
3 Supplemental Tables 1 and 2 are available with the online posting of this paper at jn.nutrition.org. ![]()
8 S.L. and B.B. are considered equal first authors. ![]()
9 Abbreviations used: cdk, cyclin-dependent kinase; CETP, cholesterol ester transfer protein; CHOL, cholesterol; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; HPSO, high-palmitic sunflower oil; LCPUFA, long-chain (n-3) PUFA; LpL, lipoprotein lipase; netAUC, net incremental area under the curve; ROO, refined olive oil; TG, triacylglycerol; TRL, TG-rich lipoprotein; VEFO, mixture of vegetable and fish oil. ![]()
Manuscript received 3 April 2007. Initial review completed 18 April 2007. Revision accepted 20 June 2007.
| LITERATURE CITED |
|---|
|
|
|---|
1. Hyson D, Rutledge JC, Berglund L. Postprandial lipemia and cardiovascular disease. Curr Atheroscler Rep. 2003;5:437–44.[Medline]
2. Tanaka A. Postprandial hyperlipidemia and atherosclerosis. J Atheroscler Thromb. 2004;11:322–9.[Medline]
3. Williams CM. Dietary interventions affecting chylomicron and chylomicron remnant clearance. Atherosclerosis. 1998;141 Suppl 1:S87–92.
4. Chung BH, Cho BHS, Liang P, Doran S, Osterlund L, Oster RA, Darnell B, Franklin F. Contribution of postprandial lipemia to the dietary fat-mediated changes in endogenous lipoprotein-cholesterol concentrations in humans. Am J Clin Nutr. 2004;80:1145–58.
5. Tholstrup T, Sandström B, Bysted A, Holmer G. Effect of 6 dietary fatty acids on the postprandial lipid profile, plasma fatty acids, lipoprotein lipase, and cholesterol ester transfer activities in healthy young men. Am J Clin Nutr. 2001;73:198–208.
6. Davidson MH. Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am J Cardiol. 2006;98 Suppl 1:27–33.
7. Jackson KG, Wolstencroft EJ, Bateman PA, Yaqoob P, Williams CM. Greater enrichment of triacylglycerol-rich lipoproteins with apolipoproteins E and C–III after meals rich in saturated fatty acids than after meals rich in unsaturated fatty acids. Am J Clin Nutr. 2005;81:25–34.
8. Thomsen C, Rasmusen O, Lousen T, Holst JJ, Fenselau S, Schrezenmeir J, Hermansen K. Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects. Am J Clin Nutr. 1999;69:1135–43.
9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.
10. Institute of Medicine, Food and Nutrition Board. Dietary reference intakes energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Washington: National Academies Press; 2002.
11. Kolovou GD, Anagnostopoulou KK, Daskalopoulou SS, Mikhailidis DP, Cokkinos DV. Clinical relevance of postprandial lipaemia. Curr Med Chem. 2005;12:1931–45.[Medline]
12. Llodra J, Angeli V, Liu J, Trogan E, Fisher EA, Randolph GJ. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci USA. 2004;101:11779–84.
13. Glass CK, Witztum JL. Atherosclerosis. The road ahead. Cell. 2001;104:503–16.
14. Yu KCW, Mamo JCL. Chylomicron-remnant-induced foam cell formation and cytotoxicity: a possible mechanism of cell death in atherosclerosis. Clin Sci. 2000;98:183–92.[Medline]
15. Bobryshev YV. Monocyte recruitment and foam cell formation in atherosclerosis. Micron. 2006;37:208–22.[Medline]
16. Choudhury RP, Lee JM, Greaves DR. Mechanisms of disease: macrophage-derived foam cells emerging as therapeutic targets in atherosclerosis. Nat Clin Pract Cardiovasc Med. 2005;2:309–15.[Medline]
17. Brinton EA, Nanjee MN, Hopkins PN. Triglyceride-rich lipoprotein remnant levels and metabolism. J Am Coll Cardiol. 2004;43:2233–5.
18. Morel O, Toti F, Hugel B, Bakouboula B, Camoin-Jau L, Dignat-George F, Freyssinet JM. Procoagulant microparticles. Disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol. 2006;26:2594–604.
19. Liu ML, Reilly MP, Casasanto P, McKenzie SE, Williams KJ. Cholesterol enrichment of human monocyte/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles. Arterioscler Thromb Vasc Biol. 2007;27:430–5.
20. Tabas I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler Thromb Vasc Biol. 2005;25:2255–64.
21. Ludewig B, Laman JD. The in and out of monocytes in atherosclerotic plaques: balancing inflammation through migration. Proc Natl Acad Sci USA. 2004;101:11529–30.
22. Pacheco YM, Bermudez B, Lopez S, Abia R, Villar J, Muriana FJG. Ratio of oleic to palmitic acid is a dietary determinant of thrombogenic and fibrinolytic factors during the postprandial state in men. Am J Clin Nutr. 2006;84:342–9.
23. EEC. Commission regulation (EEC) n° 796/02 of 6 May 2002 amending regulation EEC2568/91 on the characteristics of olive oil and olive residue oil and on the relevant methodology analysis. Off J Eur Commun. 2002;L128:8–28.
24. Abia R, Pacheco YM, Perona JS, Montero E, Muriana FJG, Ruiz-Gutierrez V. The metabolic availability of dietary triacylglycerols from two high oleic oils during the postprandial period does not depend on the amount of oleic acid ingested by healthy men. J Nutr. 2001;131:59–65.
25. Garces R, Mancha M. One-step lipid extraction and fatty acid methyl esters preparation from fresh plant tissues. Anal Biochem. 1993;211:139–43.[Medline]
26. Bello RI, Gomez-Diaz C, Lopez-Lluch G, Forthoffer N, Cordoba-Pedregosa MC, Navas P, Villalba JM. Dicoumarol relieves serum withdrawal-induced G0/1 blockade in HL-60 cells through a superoxide-dependent mechanism. Biochem Pharmacol. 2005;69:1613–25.[Medline]
27. Edwards K, Chan RY, Sawyer WH. Interactions between fatty acids and lipoprotein lipase: specific binding and complex formation. Biochemistry. 1994;33:13304–11.[Medline]
28. Park Y, Harris WS. Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. J Lipid Res. 2003;44:455–63.
29. Park Y, Jones PG, Harris WS. Triacylglycerol-rich lipoprotein margination: a potential surrogate for whole-body lipoprotein lipase activity and effects of eicosapentaenoic and docosahexaenoic acids. Am J Clin Nutr. 2004;80:45–50.
30. Blackburn P, Cote M, Lamarche B, Couillard C, Pascot A, Tremblay A, Bergeron J, Lemieux I, Despres JP. Impact of postprandial variation in triglyceridemia on low-density lipoprotein particle size. Metabolism. 2003;52:1379–86.[Medline]
31. Lagrost L, Mensink RP, Guyard-Dangremont V, Temme EHM, Desrumaux C, Athias A, Hornstra G, Gambert P. Variations in serum cholesteryl ester transfer and phospholipid transfer activities in healthy women and men consuming diets enriched in lauric, palmitic or oleic acids. Atherosclerosis. 1999;142:395–402.[Medline]
32. Callow J, Summers LKM, Bradshaw H, Frayn KN. Changes in LDL particle composition after the consumption of meals containing different amounts and types of fats. Am J Clin Nutr. 2002;76:345–50.
33. Perez-Mendez O, Alvarez-Salcedo P, Carreon E, Luc G, Arce M, De la Peña A, Cruz D, Garcia JJ, Vargas-Alarcon G. Palmitic acid in HDL is associated to low apo A-I fractional catabolic rates in vivo. Clin Chim Acta. 2007;378:53–8.[Medline]
34. Bagdade JD, Ritter M, Subbaiah PV. Marine lipids normalize cholesteryl ester transfer in IDDM. Diabetologia. 1996;39:487–91.[Medline]
35. Chung BH, Segrest JP, Smith K, Griffin FM, Brouillette CG. Lipolytic surface remnants of triglyceride-rich lipoproteins are cytotoxic to macrophages but not in the presence of high density lipoprotein. A possible mechanism of atherogenesis? J Clin Invest. 1989;83:1363–74.[Medline]
36. Iturralde M, Gamen S, Pardo J, Bosque A, Pineiro A, Alava MA, Naval J, Anel A. Saturated free fatty acid release and intracellular ceramide generation during apoptosis induction are closely related processes. Biochim Biophys Acta. 2003;1634:40–51.[Medline]
37. Lupi R, Del Guerra S, Fierabracci V, Marselli L, Novelli M, Patane G, Boggi U, Mosca F, Piro S, et al. Lipotoxicity in human pancreatic islets and the protective effect of metformin. Diabetes. 2002;51 Suppl 1:S134–7.
38. Listenberger LL, Han X, Lewis SE, Cases S, Farese RV Jr, Ory DS, Schaffer JE. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci USA. 2003;100:3077–82.
39. Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr. 2004;79:935–45.
40. Ting HJ, Stice JP, Schaff UY, Hui DY, Rutledge JC, Knowlton AA, Passerini AG, Simon SI. Triglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-alpha. Circ Res. 2007;100:381–90.
41. Berthier A, Lemaire-Ewing S, Prunet C, Monier S, Athias A, Bessede G, Pais de Barros JP, Laubriet A, Gambert P, et al. Involvement of a calcium-dependent dephosphorylation of BAD associated with the localization of Trpc-1 within lipid rafts in 7-ketocholesterol-induced THP-1 cell apoptosis. Cell Death Differ. 2004;11:897–905.[Medline]
42. Seo T, Qi K, Chang C, Liu Y, Worgall TS, Ramakrishnan R, Deckelbaum RJ. Saturated fat-rich diet enhances selective uptake of LDL cholesteryl esters in the arterial wall. J Clin Invest. 2005;115:2214–22.[Medline]
43. Tabas I. Apoptosis and plaque destabilization in atherosclerosis: the role of macrophage apoptosis induced by cholesterol. Cell Death Differ. 2004;11:S12–6.[Medline]
44. Qiu G, Ho AC, Yu W, Hill JS. Suppression of endothelial or lipoprotein lipase in THP-1 macrophages attenuates proinflammatory cytokine secretion. J Lipid Res. 2007;48:385–94.
45. Albi E, Viola Magni MO. The role of intranuclear lipids. Biol Cell. 2004;96:657–67.[Medline]
46. Morgan DO. Principles of CDK regulation. Nature. 1995;374:131–4.[Medline]
47. Siddiqui RA, Jenski LJ, Harvey KA, Wiesehan JD, Stillwell W, Zaloga GP. Cell-cycle in Jurkat leukaemic cells: a possible role for docosahexaenoic acid. Biochem J. 2003;371:621–9.[Medline]
48. Menendez JA, Vellon L, Colomer R, Lupu R. Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erb B-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (HerceptinTM) in breast cancer cells with Her-2/neu oncogene amplification. Ann Oncol. 2005;16:359–71.
49. Khan NA, Nishimura K, Aires V, Yamashita T, Oaxaca-Castillo D, Kashiwagi K, Igarashi K. Docosahexaenoic acid inhibits cancer cell growth via p27Kip1, CDK2, ERK1/ERK2, and retinoblastoma phosphorylation. J Lipid Res. 2006;47:2306–13.
This article has been cited by other articles:
![]() |
S. Lopez, B. Bermudez, Y. M Pacheco, J. Villar, R. Abia, and F. J. Muriana Distinctive postprandial modulation of {beta} cell function and insulin sensitivity by dietary fats: monounsaturated compared with saturated fatty acids Am. J. Clinical Nutrition, September 1, 2008; 88(3): 638 - 644. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||